Intrinsic Value of S&P & Nasdaq Contact Us

Marsh & McLennan Companies, Inc. MRSH NYSE

NYSE • Financial Services • Insurance - Brokers • US • USD

SharesGrow Score
66/100
4/7 Pass
SharesGrow Intrinsic Value
$197.00
+14%
Analyst Price Target
$212.82
+23.1%

Marsh & McLennan Companies, Inc. (MRSH) generated $5.29B in operating cash flow for fiscal year 2025. After capital expenditures of $291M, free cash flow was $5B.

Free cash flow margin was 18.5% of revenue. Cash conversion ratio was 1.25x, indicating earnings are backed by cash.

The company returned $1.7B in dividends and $2.01B in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (73/100, Pass) — $5B (18.5% FCF margin) supports a durable competitive advantage
  • INCOME (70/100) — Cash conversion ratio was 1.25x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 66/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
66/100
SG Score
View full scorecard →
~
VALUE
48/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
46/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
73/100
Proven by this page
GROWTH
73/100
→ Income
INCOME
70/100
→ Income
Marsh & McLennan Companies, Inc. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $5.29B$5.29B$4.3B$4.26B$3.47B
Capital Expenditure $-291M$-291M$-316M$-416M$-470M
Free Cash Flow $5B$5B$3.99B$3.84B$3B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message